RecruitingNCT07007065
Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD)
PHASE3 · 561 planned enrolment
- Countries listed
- 17
- Registry update
- September 15, 2026